Free Trial

Arbuthnot Banking Group (ARBB) Competitors

Arbuthnot Banking Group logo
GBX 920 -7.50 (-0.81%)
As of 05/21/2025 09:49 AM Eastern

ARBB vs. DOCS, WIX, YOU, CNIC, NET, SRAD, GVP, SLP, CYN, and INSE

Should you be buying Arbuthnot Banking Group stock or one of its competitors? The main competitors of Arbuthnot Banking Group include Dr. Martens (DOCS), Wickes Group (WIX), YouGov (YOU), CentralNic Group (CNIC), Netcall (NET), Stelrad Group (SRAD), Gabelli Value Plus+ Trust (GVP), Sylvania Platinum (SLP), CQS Natural Resources Growth and Income (CYN), and Inspired (INSE). These companies are all part of the "computer software" industry.

Arbuthnot Banking Group vs.

Arbuthnot Banking Group (LON:ARBB) and Dr. Martens (LON:DOCS) are both small-cap financial services companies, but which is the better investment? We will contrast the two companies based on the strength of their institutional ownership, valuation, community ranking, analyst recommendations, media sentiment, profitability, earnings, dividends and risk.

Arbuthnot Banking Group has a beta of 1, suggesting that its stock price has a similar volatility profile to the S&P 500.Comparatively, Dr. Martens has a beta of 0.11, suggesting that its stock price is 89% less volatile than the S&P 500.

Arbuthnot Banking Group pays an annual dividend of GBX 47 per share and has a dividend yield of 5.1%. Dr. Martens pays an annual dividend of GBX 3 per share and has a dividend yield of 5.3%. Arbuthnot Banking Group pays out 24.9% of its earnings in the form of a dividend. Dr. Martens pays out 42.5% of its earnings in the form of a dividend. Both companies have healthy payout ratios and should be able to cover their dividend payments with earnings for the next several years.

In the previous week, Dr. Martens had 3 more articles in the media than Arbuthnot Banking Group. MarketBeat recorded 3 mentions for Dr. Martens and 0 mentions for Arbuthnot Banking Group. Arbuthnot Banking Group's average media sentiment score of 0.00 beat Dr. Martens' score of -0.19 indicating that Arbuthnot Banking Group is being referred to more favorably in the media.

Company Overall Sentiment
Arbuthnot Banking Group Neutral
Dr. Martens Neutral

Dr. Martens has higher revenue and earnings than Arbuthnot Banking Group. Arbuthnot Banking Group is trading at a lower price-to-earnings ratio than Dr. Martens, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Arbuthnot Banking Group£239.83M0.62£30.60M£189.024.87
Dr. Martens£874.20M0.62£68.97M£7.057.97

Arbuthnot Banking Group has a net margin of 12.76% compared to Dr. Martens' net margin of 7.89%. Dr. Martens' return on equity of 18.91% beat Arbuthnot Banking Group's return on equity.

Company Net Margins Return on Equity Return on Assets
Arbuthnot Banking Group12.76% 12.11% 0.75%
Dr. Martens 7.89%18.91%8.12%

Dr. Martens has a consensus target price of GBX 6,000, indicating a potential upside of 10,566.67%. Given Dr. Martens' stronger consensus rating and higher probable upside, analysts clearly believe Dr. Martens is more favorable than Arbuthnot Banking Group.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Arbuthnot Banking Group
0 Sell rating(s)
0 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
0.00
Dr. Martens
0 Sell rating(s)
1 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
2.00

20.0% of Arbuthnot Banking Group shares are held by institutional investors. Comparatively, 69.5% of Dr. Martens shares are held by institutional investors. 64.3% of Arbuthnot Banking Group shares are held by insiders. Comparatively, 4.4% of Dr. Martens shares are held by insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a company is poised for long-term growth.

Arbuthnot Banking Group received 125 more outperform votes than Dr. Martens when rated by MarketBeat users. However, 84.62% of users gave Dr. Martens an outperform vote while only 56.67% of users gave Arbuthnot Banking Group an outperform vote.

CompanyUnderperformOutperform
Arbuthnot Banking GroupOutperform Votes
136
56.67%
Underperform Votes
104
43.33%
Dr. MartensOutperform Votes
11
84.62%
Underperform Votes
2
15.38%

Summary

Dr. Martens beats Arbuthnot Banking Group on 12 of the 19 factors compared between the two stocks.

Get Arbuthnot Banking Group News Delivered to You Automatically

Sign up to receive the latest news and ratings for ARBB and its competitors with MarketBeat's FREE daily newsletter.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of LON and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

ARBB vs. The Competition

MetricArbuthnot Banking GroupBanks IndustryFinancial SectorLON Exchange
Market Cap£148.91M£6.80B£5.34B£2.68B
Dividend Yield5.03%4.25%4.18%5.05%
P/E Ratio4.878.8212.76134.32
Price / Sales0.6245.371,770.92203,702.46
Price / Cash0.1214.2549.7128.02
Price / Book0.580.631.343.79
Net Income£30.60M£16.75B£1.22B£5.89B
7 Day Performance-1.60%1.69%0.55%0.65%
1 Month Performance1.66%7.21%11.25%22.12%
1 Year Performance0.82%20.49%13.17%119.61%

Arbuthnot Banking Group Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
ARBB
Arbuthnot Banking Group
N/AGBX 920
-0.8%
N/A-3.4%£148.91M£239.83M4.87799Gap Up
DOCS
Dr. Martens
2.8135 of 5 stars
GBX 58.27
-2.5%
N/A-35.1%£565.66M£874.20M8.26890Dividend Cut
Analyst Forecast
Gap Down
WIX
Wickes Group
2.2406 of 5 stars
GBX 214.68
+0.3%
GBX 189
-12.0%
+51.9%£508.30M£1.45B17.365,930Analyst Forecast
YOU
YouGov
2.8118 of 5 stars
GBX 301.50
-0.2%
GBX 880
+191.9%
-64.1%£352.80M£335.28M-153.651,820Gap Down
CNIC
CentralNic Group
N/AN/AN/AN/A£339.82M£790.04M-12,660.00100
NET
Netcall
1.4465 of 5 stars
GBX 112
+0.4%
GBX 130
+16.1%
+22.4%£185.13M£39.16M31.543,220
SRAD
Stelrad Group
N/AGBX 135
-2.2%
N/A+14.0%£179.35M£306.97M11.602,960Gap Up
GVP
Gabelli Value Plus+ Trust
N/AN/AN/AN/A£155.29MN/A0.00310Gap Down
SLP
Sylvania Platinum
N/AGBX 47.65
+1.4%
N/A-22.8%£153.78M£99.97M22.33160Positive News
CYN
CQS Natural Resources Growth and Income
N/AGBX 198.15
-0.2%
N/A-5.0%£124.60M£12.63M14.0840
INSE
Inspired
N/AGBX 69
-0.7%
N/A-26.6%£110.16M£155.87M63.181,600Gap Up

Related Companies and Tools


This page (LON:ARBB) was last updated on 5/22/2025 by MarketBeat.com Staff
From Our Partners